在每次电治疗课程之前服用的基他胺亚麻醉剂量改善了抗抑郁药和睡眠质量结果:一项随机对照试验
Jun Dong1, Su Min1, Qibing Chen1
1From the Department of Anesthesiology, The First Affiliated Hospital of Chongqing Medical University.
The journal of ECT
|June 13, 2023
概括
在接受电治疗 (ECT) 的患者中,亚麻醉式胺改善了睡眠质量和抑郁症状. 这一发现表明胺可以增强ECT.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 临床医学 临床医学
背景情况:
- 大型抑郁症 (MDD) 通常涉及睡眠障碍.
- 电疗法 (ECT) 是重症MDD的有效治疗方法.
- 辅助治疗的作用,以提高ECT的疗效和患者体验是一个正在进行的研究领域.
研究的目的:
- 为了研究低麻醉剂量的胺对接受双时间电心治疗的MDD患者的睡眠质量和抑郁症状的影响.
- 为了比较患者接受ect与胺与ect与盐水之间的结果.
主要方法:
- 一项随机对照试验涉及71名患有睡眠障碍的MDD患者.
- 参与者被分配到不含胺的ECT (ES组) 或以ECT辅助的胺 (KS组).
- 用24项汉密尔顿抑郁评分表来评估抑郁症状,用中国匹兹堡睡眠质量指数来评估睡眠质量.
主要成果:
- 接受胺辅助ECT (KS组) 的患者经历了更短的ECT治疗会话.
- 与KS组相比,ES组患者的睡眠效率较低,睡眠延迟较长,睡眠药物需求增加.
- 胺的使用与改善睡眠质量和减少抑郁症状有关.
结论:
- 在接受ECT的MDD患者中,低麻醉剂量的胺胺对睡眠质量产生了积极的影响.
- 胺似乎增强了ECT的治疗效果,特别是在同时出现睡眠障碍的患者中.
- 辅助胺可以提供一种策略,以改善治疗结果和患者在MDD的ECT期间的幸福感.
相关概念视频
01:30Electroconvulsive Therapy
77
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
77
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
205
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
205
01:23Sedatives and Hypnotics: Overview
478
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
478
01:24Substance Use Disorders Affecting Sleep
199
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
199
01:14CNS Depressants: Barbiturates and Benzodiazepines
350
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
350
01:20Antiepileptic Drugs: Potassium Channel Activators
218
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
218